Preliminary results from one of the earliest clinical trials of CRISPR—Cas9 provide evidence that the technique is safe and feasible to use for treating human diseases. #ResearchHighlight https://t.co/ffiOldTuJI

https://twitter.com/nature/status/1228321896816619521?s=09